Analysis of National Drug Master Data Characteristics in Supporting Pharmaceutical Management through the Pharmaceutical Information System in Indonesia, 2020–2025

Authors

  • Isma Oktadiana Universitas Efarina, North Sumatra, Indonesia

DOI:

https://doi.org/10.38035/dhps.v4i1.3667

Keywords:

National Drug Master Data, Pharmaceutical Management, Pharmaceutical Information System, Data Quality, Digital Health Transformation, E-Logistics Data Bank

Abstract

Digital health transformation requires accurate, complete, and standardized data to support information-based pharmaceutical management. The National Drug Master Data serves as a primary reference to maintain consistent drug information across pharmaceutical information systems. This study aimed to analyze the characteristics of the National Drug Master Data in supporting pharmaceutical information systems in Indonesia during 2020–2025. A quantitative descriptive design was applied using secondary data obtained from the E-Logistics Data Bank of the Ministry of Health of the Republic of Indonesia. A total of 470 drug records were analyzed using descriptive statistics based on object categories, administrative status, data creator organizations, update patterns, and attribute completeness. The results showed that 89.57% of records were categorized as Approved, with drug objects representing the largest proportion (70.43%). Primary identification attributes achieved 100% completeness, while generic name, drug category, and creator organization attributes reached 30%, 52.13%, and 78.72%, respectively. These findings indicate that the National Drug Master Data has a strong structural foundation but requires improvement in attribute completeness, metadata standardization, and data governance to enhance interoperability of national pharmaceutical information systems.

References

Ahluwalia, K., Abernathy, M. J., Beierle, J., Cauchon, N. S., Cronin, D., Gaiki, S., Lennard, A., Mady, P., McGorry, M., Sugrue-Richards, K., & Xue, G. (2022). The Future of CMC Regulatory Submissions: Streamlining Activities Using Structured Content and Data Management. In Journal of Pharmaceutical Sciences (Vol. 111, Number 5). https://doi.org/10.1016/j.xphs.2021.09.046

Almeman, A. (2024). The digital transformation in pharmacy: embracing online platforms and the cosmeceutical paradigm shift. In Journal of Health, Population and Nutrition (Vol. 43, Number 1). https://doi.org/10.1186/s41043-024-00550-2

Antar, A., Abdel-Rehiem, E. S., Al-Khalaf, A. A., Abuelsaad, A. S. A., Abdel-Gabbar, M., Shehab, G. M. G., & Abdel-Aziz, A. M. (2025). Therapeutic Efficacy of Lavandula dentata’s Oil and Ethanol Extract in Regulation of the Neuroinflammation, Histopathological Alterations, Oxidative Stress, and Restoring Balance Treg Cells Expressing FoxP3+ in a Rat Model of Epilepsy. Pharmaceuticals, 18(1). https://doi.org/10.3390/ph18010035

Beierle, J., Algorri, M., Cortés, M., Cauchon, N. S., Lennard, A., Kirwan, J. P., Oghamian, S., & Abernathy, M. J. (2023). Structured content and data management—enhancing acceleration in drug development through efficiency in data exchange. AAPS Open, 9(1). https://doi.org/10.1186/s41120-023-00077-6

Chen, N., & Fang, J. (2025). The aggregate release of third-party online sales data and audit quality improvement. China Journal of Accounting Research, 18(1). https://doi.org/10.1016/j.cjar.2024.100376

DAMA International. (2017). Data Management Body of Knowledge (2nd Edition). In Technics Publications, LLC14 Elm StDenvilleNJUnited States (Vol. 44, Number 8).

Ehrlinger, L., & Wöß, W. (2022). A Survey of Data Quality Measurement and Monitoring Tools. In Frontiers in Big Data (Vol. 5). https://doi.org/10.3389/fdata.2022.850611

Faradiba, Satibi, & Lazuardi, L. (2023). Development of a Drug Management Performance Application: A Needs Assessment in Indonesia. Healthcare Informatics Research, 29(2). https://doi.org/10.4258/hir.2023.29.2.103

Fu, Q., Nicholson, G. L., & Easton, J. M. (2024). Understanding data quality in a data-driven industry context: Insights from the fundamentals. In Journal of Industrial Information Integration (Vol. 42). https://doi.org/10.1016/j.jii.2024.100729

Hikmawati, S., Santosa, P. I., & Hidayah, I. (2021). Improving Data Quality and Data Governance Using Master Data Management: A Review. IJITEE (International Journal of Information Technology and Electrical Engineering), 5(3). https://doi.org/10.22146/ijitee.66307

Hosseinzadeh, E., Afkanpour, M., Momeni, M., & Tabesh, H. (2025). Data quality assessment in healthcare, dimensions, methods and tools: a systematic review. In BMC Medical Informatics and Decision Making (Vol. 25, Number 1). https://doi.org/10.1186/s12911-025-03136-y

Idris, S. A., Hussien, T. M. A., Al-Shammari, F. F., Nagi, H. A., Bashir, A. I., Elhussein, G. E. M. O., Abdalla, R. A. H., Mohammed, H. M. E., Abdelaziz, W. E., Alshammari, A. D., Alreshidi, H. F. H., Alshammari, H. N. M., & Ibrahim, S. I. B. (2024). An Evaluation of Drug Prescribing Patterns and Prescription Completeness. Healthcare (Switzerland), 12(22). https://doi.org/10.3390/healthcare12222221

ISO 8000-61. (2016). Data quality-Part 61: Data quality management: Process reference model ISO 8000-61 ISO 8000-61:2016(E). In ISO 8000-61:2016(E).

Kesehatan, kementrian. (2025). Mengenal Pengertian SATUSEHAT. Https://Kemkes.Go.Id/Id/Mengenal-Pengertian-Satusehat.

Martono, N. (2014). METODE PENELITIAN KUANTITATIF: Analisis Isi dan Analisis Data Sekunder ... - Nanang Martono - Google Buku. Jakarta: Rajawali Pers.

Netinant, P., Saengsuwan, N., Rukhiran, M., & Pukdesree, S. (2023). Enhancing Data Management Strategies with a Hybrid Layering Framework in Assessing Data Validation and High Availability Sustainability. Sustainability (Switzerland), 15(20). https://doi.org/10.3390/su152015034

Newswire, P. R. (2018). Global e-Clinical Trial Technologies Industry. In LON-REPORTBUYER.

Papastergios, V., Ehrlinger, L., & Gounaris, A. (2026). Unfolding Data Quality Dimensions in Practice: A Survey. Journal of Data and Information Quality, 18(1). https://doi.org/10.1145/3786328

Popescu, C., EL-Chaarani, H., EL-Abiad, Z., & Gigauri, I. (2022). Implementation of Health Information Systems to Improve Patient Identification. International Journal of Environmental Research and Public Health, 19(22). https://doi.org/10.3390/ijerph192215236

Ritter, C. (2025). Digital learning methods in pharmacy. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 68(5). https://doi.org/10.1007/s00103-025-04041-5

Sharma, L., Prakash, A., & Medhi, B. (2024). Ensuring medication and patient safety for better quality healthcare. In Indian Journal of Pharmacology (Vol. 56, Number 6). https://doi.org/10.4103/ijp.ijp_109_25

Stoumpos, A. I., Kitsios, F., & Talias, M. A. (2023). Digital Transformation in Healthcare: Technology Acceptance and Its Applications. International Journal of Environmental Research and Public Health, 20(4). https://doi.org/10.3390/ijerph20043407

Uslu, A., & Stausberg, J. (2021). Value of the Electronic Medical Record for Hospital Care: Update from the Literature. In Journal of Medical Internet Research (Vol. 23, Number 12). https://doi.org/10.2196/26323

WHO. (2021). Global strategy on digital health 2020-2025. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO. In Who.

Published

2026-07-30

How to Cite

Oktadiana, I. (2026). Analysis of National Drug Master Data Characteristics in Supporting Pharmaceutical Management through the Pharmaceutical Information System in Indonesia, 2020–2025. Dinasti Health and Pharmacy Science, 4(1), 58–69. https://doi.org/10.38035/dhps.v4i1.3667